CING
Cingulate Inc
NASDAQ: CING · HEALTHCARE · BIOTECHNOLOGY
$4.71
+0.64% today
Updated 2026-04-29
Market cap
$67.01M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.44
Dividend yield
—
52W range
$3 – $12
Volume
0.5M
Cingulate Inc (CING) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.53M | $-6.81M | $-10.43M | $-15.88M | $-15.03M | $-18.45M | $-17.25M |
| Capital expenditures | $1.02M | $402096.00 | $814736.00 | $153420.00 | $224096.00 | $211800.00 | $162138.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $12.78M | $800796.00 | $812670.00 | $995484.00 | $1.52M |
| Free cash flow | $-10.55M | $-7.21M | $-11.25M | $-16.04M | $-15.26M | $-18.66M | $-17.41M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |